Related Experiment Video
Updated: Mar 27, 2026
Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
Maternal hyperuricemia and adverse maternal-fetal outcomes: a systematic review and meta-analysis of observational
Ahmed Abu-Zaid1, Khawlah Habib AlShammari2, Sara N Alenezi2
1Department of Biochemistry and Molecular Medicine, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Background:
Maternal serum uric acid (SUA) has been suggested as a biomarker for adverse pregnancy outcomes, but findings remain inconsistent. This systematic review and meta-analysis evaluated the association between elevated maternal SUA levels and key obstetric and neonatal outcomes.
Methods:
A comprehensive search of PubMed, Scopus, Web of Science, and the Cochrane Library was conducted through December 2024. Observational studies reporting associations between high maternal SUA levels and pregnancy outcomes were included. Data were pooled using a random-effects model as odds ratios (ORs). Heterogeneity was assessed using the I 2 statistic.
Results:
A total of 30 studies met the inclusion criteria. Elevated maternal SUA levels were significantly associated with increased odds of preterm birth (PTB; OR = 2.05, 95% CI: 1.55-2.72, I 2 = 90.22%, n = 20), preeclampsia (PE; OR = 3.84, 95% CI: 2.17-6.77, I 2 = 92.35%, n = 8), neonatal intensive care unit (NICU) admission (OR = 2.20, 95% CI: 1.63-2.97, I 2 = 0.00%, n = 5), cesarean delivery (OR = 1.44, 95% CI: 1.16-1.79, I 2 = 92.59%, n = 8), and intrauterine growth restriction (IUGR; OR = 3.03, 95% CI: 1.16-7.91, I 2 = 84.23%, n = 8). Elevated SUA levels were also associated with low Appearance, Pulse, Grimace, Activity, and Respiration scores at 1 min (OR = 3.63, 95% CI: 1.47-8.95, I 2 = 62.75%, n = 4) and 5 min (OR = 4.66, 95% CI: 2.45-8.85, I 2 = 0%, n = 4). Conversely, high SUA levels were associated with reduced odds of spontaneous vaginal delivery (SVD; OR = 0.68, 95% CI: 0.51-0.91, I 2 = 93.29%, n = 8) and a non-significant reduction in live birth (OR = 0.65, 95% CI: 0.41-1.02, I 2 = 55.98%, n = 4).
Conclusion:
This meta-analysis shows an association between elevated maternal SUA levels and adverse maternal and neonatal outcomes. However, the evidence is derived from heterogeneous observational studies and does not support causal inference or routine SUA-based screening in clinical practice. Maternal SUA may be a promising biomarker, but large, well-designed prospective studies are needed to validate these findings and clarify its incremental predictive value.
Systematic Review Registration:
CRD420251038421, https://www.crd.york.ac.uk/PROSPERO/view/CRD420251038421.
More Related Videos
Related Concept Videos
01:07Teratogenicity
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
01:22Diabetes Mellitus: Type 2 and Gestational